Identification of co-morbidities requiring further assessment using the ‘stop-go’ tool and relationship between screen results and actual co-morbidities identified by ad hoc healthcare contact over 1 year
| STOP | GO | New diagnoses at 1 year | |||||
|---|---|---|---|---|---|---|---|
| Screen negative n (%) | Prior diagnosis n (%) | Screen positive n (%) | Data not available n (%) | n | Go n(%) | Stop n(%) | |
| Hypertension (BP <130/90) | 20 (17) | 62 (52) | 23 (19) | 15 (13) | 12 | 11 (92) | 1 (8) |
| Atrial Fibrillation (Sinus rhythm on ECG) | 71 (59) | 21 (18) | 1 (1) | 27 (23) | 7 | 3 (43) | 4 (57) |
| Ischaemic heart disease (No CVS symptoms) | 44 (37) | 50 (42) | 6 (5) | 20 (17) | 7 | 4 (57) | 3 (43) |
| Congestive cardiac failure (BNP <100 pg/ml) | 39 (33) | 29 (24) | 33 (28) | 19 (16) | 6 | 5 (83) | 1 (17) |
| Dyslipidaemia (QRISK2 score <10%) | 11 (9) | 64 (53) | 27 (23) | 18 (15) | 2 | 1 (50) | 1 (50) |
| Diabetes mellitus (HbA1C ≤42 mmol/mol) | 60 (50) | 22 (18) | 9 (8) | 29 (24) | 7 | 4 (57) | 3 (43) |
| Depression (HADS-D <10) | 1 (1) | 20 (17) | 0 (0) | 99 (83) | 4 | 4 (100) | 0 (0) |
| Anxiety (HADS-A <10) | 1 (1) | 6 (5) | 0 (0) | 113 (94) | 7 | 7 (100) | 0 (0) |
| Cognitive impairment (AMTS ≥7) | 73 (61) | 7 (6) | 6 (5) | 34 (28) | 6 | 5 (83) | 1 (17) |
| Osteoporosis (No history of fragility # and no oral corticosteroids for ≥3 months) | 9 (8) | 18 (15) | 82 (68) | 11 (9) | 11 | 11 (100) | 0 (0) |
| Chronic kidney disease (eGFR ≥60ml/min/1.73m2 at discharge) | 99 (83) | 3 (3) | 17 (14) | 1 (1) | N/A | N/A | N/A |
| Anaemia (Hb ≥120 g/L at discharge) | 88 (73) | 3 (3) | 28 (23) | 1 (1) | N/A | N/A | N/A |
AMTS (Abbreviated Mental Test Score), BNP (BB-type Natriuretic Pepetide),CVS (Cardiovascular system), eGFR (Estimated Glomerular Filtration Rate), HADS-A/D (Hospital Anxiety and Depression Scale), Hb (Haemoglobin), HbA1c (Glycated Haemoglobin), # (fracture).